Mark Ragosa - Net Worth and Insider Trading

Mark Ragosa Net Worth

The estimated net worth of Mark Ragosa is at least $924,337 dollars as of 2026-09-11. Mark Ragosa is the CHIEF FINANCIAL OFFICER of Kiniksa Pharmaceuticals International PLC and owns about 12,086 shares of Kiniksa Pharmaceuticals International PLC (KNSA) stock worth over $924,337. Details can be seen in Mark Ragosa's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Ragosa has not made any transactions after 2026-03-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Mark Ragosa

To

Mark Ragosa Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Ragosa owns 1 companies in total, including Kiniksa Pharmaceuticals International PLC (KNSA) .

Click here to see the complete history of Mark Ragosa’s form 4 insider trades.

Insider Ownership Summary of Mark Ragosa

Ticker Company Transaction Date Type of Owner
KNSA Kiniksa Pharmaceuticals International PLC 2026-03-09 Interim CFO

Mark Ragosa Latest Holdings Summary

Mark Ragosa currently owns a total of 1 stock. Mark Ragosa owns 12,086 shares of Kiniksa Pharmaceuticals International PLC (KNSA) as of March 9, 2026, with a value of $924,337.

Latest Holdings of Mark Ragosa

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KNSA Kiniksa Pharmaceuticals International PLC 2026-03-09 12,086 76.48 924,337

Holding Weightings of Mark Ragosa


Mark Ragosa Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Ragosa has made a total of 15 transactions in Kiniksa Pharmaceuticals International PLC (KNSA) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Kiniksa Pharmaceuticals International PLC is the sale of 36,722 shares on March 9, 2026, which brought Mark Ragosa around $2 Million.

Insider Trading History of Mark Ragosa

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Ragosa Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Mark Ragosa owns.
View KNSA Analysis

Mark Ragosa Ownership Network

Ownership Network List of Mark Ragosa

No Data

Ownership Network Relation of Mark Ragosa

Insider Network Chart


Mark Ragosa Owned Company Details

What does Kiniksa Pharmaceuticals International PLC do?

Who are the key executives at Kiniksa Pharmaceuticals International PLC?

Mark Ragosa is the Interim CFO of Kiniksa Pharmaceuticals International PLC. Other key executives at Kiniksa Pharmaceuticals International PLC include Chief Accounting Officer Michael R Megna , CHIEF STRATEGY OFFICER Dhiraj H Malkani , and director & 10 percent owner & Chairman & CEO Sanj K Patel .

Kiniksa Pharmaceuticals International PLC (KNSA) Insider Trades Summary

Over the past 18 months, Mark Ragosa made 12 insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA) with a net sale of 327,650. Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 495,118 shares made by Eben Tessari , a net sale of 921,737 shares made by Sanj K Patel , and a net sale of 131,624 shares made by Michael R Megna .

In summary, during the past 3 months, insiders sold 8,273 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 8,273 shares. During the past 18 months, 2,505,236 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,505,236 shares.

Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kiniksa Pharmaceuticals International PLC Insider Transactions

No Available Data

Mark Ragosa Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Ragosa. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mark Ragosa's mailing address is: Lexington Ma 02421.